CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
CIViC Variants/EXON 11 MUTATION

EXON 11 MUTATION

CIViC ID: 86 · Gene: NPM1

Variant Summary

Also known as
EXON 12 MUTATION
HGVS
Variant Type(s)
exon_variant
Evidence Items
29

Evidence Level Distribution

Level A: 1Level B: 25Level D: 1Level E: 2

Evidence Items

Showing CIViC evidence rows where gene = NPM1 and variant = EXON 11 MUTATION.

LevelTypeDirectionSignificanceDiseaseDrugsRating
ADiagnosticSupportsPositiveAcute Myeloid Leukemia5
BPrognosticSupportsBetter OutcomeAcute Myeloid Leukemia5
BPrognosticSupportsPoor OutcomeAcute Myeloid Leukemia4
BDiagnosticSupportsNegativeAcute Myeloid Leukemia4
BDiagnosticSupportsPositiveAcute Myeloid Leukemia4
BPrognosticSupportsBetter OutcomeAcute Myeloid Leukemia4
BPrognosticSupportsBetter OutcomeAcute Myeloid Leukemia4
BPrognosticSupportsBetter OutcomeAcute Myeloid Leukemia4
BDiagnosticSupportsPositiveAcute Myeloid Leukemia3
BDiagnosticSupportsPositiveAcute Myeloid Leukemia3
BPrognosticDoes Not SupportBetter OutcomeAcute Myeloid Leukemia3
BPredictiveDoes Not SupportSensitivity/ResponseAcute Myeloid LeukemiaTretinoin3
DPredictiveSupportsSensitivity/ResponseAcute Myeloid LeukemiaTretinoin,NSC3488843
BPrognosticSupportsBetter OutcomeAcute Myeloid Leukemia3
BPrognosticSupportsBetter OutcomeAcute Myeloid Leukemia3
BPrognosticSupportsBetter OutcomeAcute Myeloid Leukemia3
BPrognosticSupportsBetter OutcomeAcute Myeloid Leukemia3
BPrognosticSupportsBetter OutcomeAcute Myeloid Leukemia3
BPrognosticSupportsBetter OutcomeAcute Myeloid Leukemia3
BPrognosticSupportsBetter OutcomeAcute Myeloid Leukemia3
BPrognosticSupportsPoor OutcomeAcute Myeloid Leukemia3
BDiagnosticSupportsPositiveAcute Myeloid Leukemia2
BPredictiveSupportsSensitivity/ResponseAcute Myeloid LeukemiaTretinoin2
BPredictiveSupportsSensitivity/ResponseAcute Myeloid LeukemiaDaunorubicin2
BPredictiveSupportsSensitivity/ResponseAcute Myeloid LeukemiaValproic Acid2
EPredictiveSupportsSensitivity/ResponseAcute Myeloid LeukemiaAnti-CD123,Anti-CD332
EPredictiveSupportsSensitivity/ResponseAcute Myeloid LeukemiaAnti-CD332
BPrognosticSupportsBetter OutcomeAcute Myeloid Leukemia2
BPrognosticSupportsPoor OutcomeAcute Myeloid Leukemia2